FEATURED PUBLICATIONS
New dawn for pharma in Japan
 |
Editor's annotation Although they are considered giants in their field, Japan’s pharma majors cannot take their future for granted. Some have already formed M&As but mega-mergers may come next. Ref.: SCRIP Magazine January 2006, pp. 20-22
|
|
Request a copy | Reading Room |
Measuring the intangible
 |
Editor's annotation
Cultural prejudices and
regulatory restrains that have crippled the Japanese pharmaceutical market
in Japan for decades are melting down. Could an innovative approach to the
pharmaceutical market research play a new role in the changing environment
for drug development in Japan?
Ref.: Current Drug Discovery,
April 2004, p. 36-39
|
|
Request a copy | Reading Room |
eCTD/CTD - Embracing the
Japan Transition
 |
Doing Business in Asia issue To remain competitive in the global marketplace, pharmaceutical companies in Japan will need to review regulatory submission strategies and integrate processes within the local submission and language requirement infrastructure. Ref: RAPS Magazine, February/March issue 2004 (members access)
|
|
Request a copy |
Japan's Public Access to Information Law
 |
Editor's annotation Considered is the transparency in Japan and the scope of the new law one year later on Ref.: Regulatory Affairs Journal, April 2002, p. 289-298 |
|
Request a copy |
Emerging e-Health
 |
Editor's annotation Another success story, the Jouhou Koukai Services ...arose from a savvy move to capitalize on the new freedom of information legislation in Japan... Ref.: SCRIP Magazine, March 2002, p. 21-24
|
|
Request a copy | Download a copy |
E-drug: Japan drug formulary
|
